The Latvian pharmaceutical concern Olainfarm has expanded its marketing team and set up fully operating representative office in Ukraine, the company said in a press release posted on the GlobeNewswire website.
According to the press release, 25 Olainfarm employees will provide a full-fledged presence in 14 cities of Ukraine, in particular, Kyiv, Dnipro, Kharkiv, Odesa and Lviv.
The capacity expansion helped to raise the company’s local impact by reaching 63,000 healthcare professionals and about 100,000 digital contacts in a 2020 campaign, executed in the second part of the year. The project contributed to the adoption of a positive decision to expand the company’s presence in Ukraine.
Olainfarm, a part of Olainfarm Group, is one of the leading pharmaceutical companies in the Baltic States offering high quality medicine and chemical pharmaceutical products. Its product portfolio includes over 60 finished dosage forms, 25 active pharmaceutical ingredients and over 20 intermediates.
Subsidiaries are located in Ukraine, Lithuania, Turkey and Kyrgyzstan, and representative offices – in the Russian Federation, Belarus, Tajikistan, Albania, Mongolia, and Uzbekistan.
